Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human anti-interferon gamma monoclonal antibody

EU orphan designation number: EU/3/10/749   
Active ingredient: Recombinant human anti-interferon gamma monoclonal antibody
Indication: Treatment of haemophagocytic lymphohistiocytosis
Sponsor: NovImmune B.V.
Prins Berhardplein 200, 1097 JB Amsterdam, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/06/2010 Orphan designation EMEA/OD/153/09 (2010)3836 of 09/06/2010